Capital Advantage’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-1,994
Closed -$263K – 81
2017
Q1
$263K Sell
1,994
-225
-10% -$28.4K 0.07% 66
2016
Q4
$266K Sell
2,219
-285
-11% -$32.8K 0.08% 65
2016
Q3
$291K Hold
2,504
– – 0.08% 61
2016
Q2
$300K Sell
2,504
-201
-7% -$22.5K 0.09% 56
2016
Q1
$290K Hold
2,705
– – 0.1% 58
2015
Q4
$251K Hold
2,705
– – 0.08% 63
2015
Q3
$255K Hold
2,705
– – 0.1% 59
2015
Q2
$259K Hold
2,705
– – 0.1% 58
2015
Q1
$250K Hold
2,705
– – 0.1% 61
2014
Q4
$255K Hold
2,705
– – 0.11% 54
2014
Q3
$218K Hold
2,705
– – 0.11% 53
2014
Q2
$228K Hold
2,705
– – 0.13% 51
2014
Q1
$220K Hold
2,705
– – 0.15% 43
2013
Q4
$203K Buy
+2,705
New +$197K 0.14% 45

Other funds holding SYK

Capital Advantage's SYK Position: Q2 2017 in Review

Capital Advantage sold out of Stryker (SYK) in Q2 2017, closing a stake of 1,994 shares — an estimated $263K sold.

Capital Advantage first reported a position in SYK in Q4 2013 and held it in 14 quarters. The position peaked at $300K in Q2 2016. 1,043 funds tracked by Wall St. Rank hold SYK as of Q2 2017.

  • Capital Advantage reported no remaining Stryker position as of Q2 2017 after selling out during the quarter.
  • Capital Advantage sold 1,994 Stryker shares in Q2 2017, an estimated $263K.
  • Capital Advantage first reported a position in Stryker in Q4 2013 and held it in 14 quarters.
  • Capital Advantage's Stryker position peaked at $300K in Q2 2016.
  • 1,043 funds tracked by Wall St. Rank held Stryker as of Q2 2017.

Based on Capital Advantage's 13F filing for Q2 2017, filed 8 Aug 2017.